Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI

Slides:

Advertisements

Similar presentations

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.

Advertisements

The Brief Cognitive Assessment Tool (BCAT): A New Test Emphasizing Contextual Memory and Executive Functions Drs. William Mansbach, Elizabeth MacDougall,

Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.

Neurocognitive Disorders

Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.

The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.

Dementia with Lewy Bodies

Alexander I. Tröster, Ph.D. Department of Neurology

Mild Cognitive Impairment

Screening for Stroke and Cognitive Impairment Chapter 2: Background.

Canadian Study of Health and Aging Disability and Frailty.

بسم الله الرحمن الرحیم. Dementia Dementia is a condition characterised by a progressive decline of mental abilities accompanied by changes in personality.

VAMC/ST LOUIS UNIVERSITY

Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.

1 TOPIC 13 COGNITIVE DISORDER.  Dissociative disorder involve changes or disturbances in identity, memory or consciousness that affect the ability to.

Alzheimer’s Disease The most common cause of Dementia –Progressive Memory Loss Plus loss in one other area of cognition: Perception Attention Language/Symbols.

Jack Twersky, MD Medical Director CLC Durham.  Memory impairment and at least one of the following  Aphasia  Apraxia  Agnosia  Executive function.

Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.

“3 D’s” of Geriatrics Dementia, Delirium, and Depression These common disorders can look alike. GAI often helps uncover or differentiate them. All are.

How to diagnose dementia? Dr. Sridhar Vaitheswaran 25 th October 2012.

MCI Conversion to Dementia: Clinic and Community-Based Studies

Understanding Mild Cognitive Impairment. Objectives Understand the concept of MCI Identify risk factors for progression to dementia Review clinical trial.

Canadian Study of Health and Aging The Prevalence of Dementia 1991 Baseline Study.

Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.

We Treat Alzheimers 20 years early? Can. Clinical neurologist-Reisa Sperling 1. Is a clinical neurologist, a neuroimaging researcher. 2.Is a leading force.

NON PHARMACOLOGICAL THERAPY OF MENTAL IMAGERY AND RELAXATION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT Poptsi Ε.,1,3, Κounti F.,1,3,Τsolaki, Μ. 1,2 1.

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Memory and Aging Educational Presentation Presented by Tessa Lundquist, M.S. University of Massachusetts Amherst.

Dement Geriatr Cogn Disord 2011;31:239– DOI: /

Volume 3, Issue 4, Pages (November 2017)

Cognitive Interventions in Mild Alzheimer's Disease: A Therapy-Evaluation Study on the Interaction of Medication and Cognitive Treatment Dement Geriatr.

Embracing Their Reality: Making Assisted Living Dementia-Friendly

Body Mass Index in Different Dementia Disorders: Results from the Swedish Dementia Quality Registry (SveDem) Dement Geriatr Cogn Disord Extra 2014;4:65-75.

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease Dement Geriatr Cogn Disord Extra.

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease Respiration 2015;90: DOI: /

Alzheimer’s Disease Group 廖元祺楊熙恆

Dement Geriatr Cogn Disord Extra 2014;4: DOI: /

Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire Roos J.

by Edward J. Goetzl, Adam Boxer, Janice B. Schwartz, Erin L

Volume 5, Pages (December 2016)

Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,

Fig. 2. Comparison of ROC curves for the FR and TR of both versions of the FCSRT for discriminating mild AD patients from cognitively healthy controls.

An amylin analog used as a challenge test for Alzheimer's disease

Abnormal Psychology Chapter 15 Neurocognitive Disorders Second Edition

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja,

Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study Dement Geriatr.

The Developing Person Through the Life Span

Cognitive Disorders and Aging

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Figure 2 Overview of risk factors for Parkinson disease dementia

Early Dementia Distinguishing AD From MCI

Chapter 93 Dementias and Related Disorders

Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment Shangran.

Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.

Development and Clinical Validity of a Mild Vascular Cognitive Impairment Assessment Tool for Korean Stroke Patients Hyun Soo Oh, PhD, RN, Ji Sun Kim,

Dementia GEC Faculty Scholars Program

The effect of preoperative cognitive impairment and type of vascular surgery procedure on postoperative delirium with associated cost implications Rima.

Baseline Characteristics of the Subjects

The validity of the Memory Alteration Test and the Test Your Memory test for community- based identification of amnestic mild cognitive impairment Seline.

Schematic overview of the immuno‐infrared‐sensor, the assay read‐out, and BioFINDER and ESTHER study design Schematic overview of the immuno‐infrared‐sensor,

Postmortem Neurological Diagnosis A Postmortem Neurological Diagnosis or Brain-Only Autopsy, is the only definitive answer for families or researchers.

Massimo S. Fiandaca, Mark E. Mapstone, Amrita K. Cheema, Howard J

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients Eric R. Siemers, Karen L. Sundell, Christopher Carlson, Michael Case,

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS Betty M. Tijms, Mara ten Kate, Sander C.J.

MCI Today, Dementia Tomorrow: Improving Clinical Strategies

ROC curves showing additive value of DHE in diagnosing ongoing episode of recurrence among all patients with established history of recurrent pericarditis.

Receiver operating characteristics curves showing discrimination between patients with dementia of the Alzheimer type (at time of diagnosis) and non-demented.

Fig. 3. Generation of induced microglia like cells from peripheral blood mononuclear cells (A) and defected microglial phagocytosis in rapidly progressive.

ROC curve for the TYM-MCI, ACE-R and MMSE in the separation of patients with aMCI/AD from those with SMC. ACE-R, Addenbrooke’s Cognitive Examinations;

Box plot showing the distribution of the TYM-MCI score for patients with SMC and aMCI/AD. aMCI/AD, amnestic mild cognitive impairment or Alzheimer’s disease;

Presentation transcript:

Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI Fig. 1.ROC curve for K-IADL to diagnose dementia or MCI. (A) ROC curve for K-IADL for diagnosing dementia in all participants (AUC = 0.959; p<0.001). (B) ROC curve for K-IADL to differentiate dementia from MCI in all participants (AUC = 0.952; p<0.001). (C) ROC curve for K-IADL to differentiate MCI from normal control in all participants (AUC = 0.765; p<0.001). (D) ROC curve for K-IADL for diagnosing dementia in patients with AD, MCI, and normal control (AUC = 0.964; p<0.001). (E) ROC curve for K-IADL for diagnosing dementia in the patients with VCI and normal control (AUC = 0.989; p<0.001). (F) ROC curve for K-IADL for diagnosing dementia in patients with PD and normal control (AUC = 0.944; p<0.001). ROC: receiver operating characteristic, K-IADL: Korean-Instrumental Activities of Daily Living, MCI: mild cognitive impairment, AUC: area under the curve, AD: Alzheimer's disease, VCI: vascular cognitive impairment, PD: Parkinson's disease. Fig. 1.ROC curve for K-IADL to diagnose dementia or MCI. (A) ROC curve for K-IADL for diagnosing dementia in all participants (AUC = 0.959; p<0.001). (B) ROC curve for K-IADL to differentiate dementia from MCI in all participants (AUC = 0.952; p<0.001). (C) ROC curve for K-IADL to differentiate MCI from normal control in all participants (AUC = 0.765; p<0.001). . Dement Neurocognitive Disord. 2018 Jan;17:e5.